rs146438406

Variant summary

Our verdict is Benign. The variant received -17 ACMG points: 0P and 17B. BP4_StrongBP6_Very_StrongBP7BS1

The NM_001182.5(ALDH7A1):​c.243A>G​(p.Arg81Arg) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000151 in 1,598,006 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.00088 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000082 ( 0 hom. )

Consequence

ALDH7A1
NM_001182.5 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -0.171

Publications

1 publications found
Variant links:
Genes affected
ALDH7A1 (HGNC:877): (aldehyde dehydrogenase 7 family member A1) The protein encoded by this gene is a member of subfamily 7 in the aldehyde dehydrogenase gene family. These enzymes are thought to play a major role in the detoxification of aldehydes generated by alcohol metabolism and lipid peroxidation. This particular member has homology to a previously described protein from the green garden pea, the 26g pea turgor protein. It is also involved in lysine catabolism that is known to occur in the mitochondrial matrix. Recent reports show that this protein is found both in the cytosol and the mitochondria, and the two forms likely arise from the use of alternative translation initiation sites. An additional variant encoding a different isoform has also been found for this gene. Mutations in this gene are associated with pyridoxine-dependent epilepsy. Several related pseudogenes have also been identified. [provided by RefSeq, Jan 2011]
ALDH7A1 Gene-Disease associations (from GenCC):
  • pyridoxine-dependent epilepsy
    Inheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: Illumina, Orphanet, ClinGen
  • pyridoxine-dependent epilepsy caused by ALDH7A1 mutant
    Inheritance: AR, AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -17 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.58).
BP6
Variant 5-126593354-T-C is Benign according to our data. Variant chr5-126593354-T-C is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 136370.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.171 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.000879 (123/139898) while in subpopulation AFR AF = 0.00319 (114/35696). AF 95% confidence interval is 0.00272. There are 0 homozygotes in GnomAd4. There are 69 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ALDH7A1NM_001182.5 linkc.243A>G p.Arg81Arg synonymous_variant Exon 2 of 18 ENST00000409134.8 NP_001173.2
ALDH7A1NM_001201377.2 linkc.159A>G p.Arg53Arg synonymous_variant Exon 2 of 18 NP_001188306.1
ALDH7A1NM_001202404.2 linkc.243A>G p.Arg81Arg synonymous_variant Exon 2 of 16 NP_001189333.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ALDH7A1ENST00000409134.8 linkc.243A>G p.Arg81Arg synonymous_variant Exon 2 of 18 1 NM_001182.5 ENSP00000387123.3

Frequencies

GnomAD3 genomes
AF:
0.000880
AC:
123
AN:
139786
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00320
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000495
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00104
GnomAD2 exomes
AF:
0.000230
AC:
57
AN:
247386
AF XY:
0.000194
show subpopulations
Gnomad AFR exome
AF:
0.00335
Gnomad AMR exome
AF:
0.0000291
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00000892
Gnomad OTH exome
AF:
0.000329
GnomAD4 exome
AF:
0.0000816
AC:
119
AN:
1458108
Hom.:
0
Cov.:
34
AF XY:
0.0000717
AC XY:
52
AN XY:
725400
show subpopulations
African (AFR)
AF:
0.00292
AC:
97
AN:
33212
American (AMR)
AF:
0.0000673
AC:
3
AN:
44594
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26076
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39608
South Asian (SAS)
AF:
0.0000116
AC:
1
AN:
86074
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53004
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5254
European-Non Finnish (NFE)
AF:
0.00000270
AC:
3
AN:
1110108
Other (OTH)
AF:
0.000249
AC:
15
AN:
60178
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.438
Heterozygous variant carriers
0
6
12
19
25
31
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000879
AC:
123
AN:
139898
Hom.:
0
Cov.:
32
AF XY:
0.00101
AC XY:
69
AN XY:
68324
show subpopulations
African (AFR)
AF:
0.00319
AC:
114
AN:
35696
American (AMR)
AF:
0.000494
AC:
7
AN:
14162
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3312
East Asian (EAS)
AF:
0.00
AC:
0
AN:
4780
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4406
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10068
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
268
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
64424
Other (OTH)
AF:
0.00103
AC:
2
AN:
1942
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.486
Heterozygous variant carriers
0
5
10
15
20
25
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000614
Hom.:
0
Bravo
AF:
0.00105

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Pyridoxine-dependent epilepsy Benign:2
Feb 02, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Apr 11, 2023
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
Jun 13, 2013
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Inborn genetic diseases Benign:1
Nov 03, 2016
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.58
CADD
Benign
9.3
DANN
Benign
0.73
PhyloP100
-0.17

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs146438406; hg19: chr5-125929046; API